Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|January 17, 2012
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysisMaurizia Dalla Palma, Michele Gregianin, Pasquale Fiduccia, et al.
Frontiers in Oncology|December 31, 2020
Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer CenterGiulia Tasca, Maria Vittoria Dieci, Zora Baretta, et al.
Tumori|June 26, 2015
Trabectedin plus pegylated liposomal doxorubicin: retrospective analysis in heavily pretreated platinum-sensitive ovarian cancerMaria Ornella Nicoletto, Alessandra Baldoni, Alessandra Casarin, et al.
Journal of Clinical Medicine|February 5, 2020
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian CancerElena Laura Mazzoldi, Anna Pastò, Giorgia Pilotto, et al.
Anticancer Research|July 24, 2010
Vulvar cancer: prognostic factorsMaria Ornella Nicoletto, Anna Parenti, Paola Del Bianco, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancerMaria Ornella Nicoletto, Roberta Bertorelle, Lucia Borgato, et al.
Oncotarget|December 30, 2016
Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cellsAnna Pastò, Anna Pagotto, Giorgia Pilotto, et al.
Oncotarget|June 21, 2014
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivationAnna Pastò, Chiara Bellio, Giorgia Pilotto, et al.
Molecular Cancer Therapeutics|August 13, 2011
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicinTamar Safra, Lucia Borgato, Maria Ornella Nicoletto, et al.
Tumori|October 1, 2008
Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancerMaria Ornella Nicoletto, Donato Nitti, Luigi Pescarini, et al.
Pageof 3